CMS finalizes Medicare Advantage rate cut: 5 things physicians should know 

CMS finalized a slight cut in Medicare Advantage benchmark payments for 2025, according to a final rate notice published April 1. 

Advertisement

Here are five notes:

1. CMS estimated plans will increase MA revenues by an average of 3.7%, or more than $16 billion, from 2024 to 2025.

2. The agency will cut benchmark payments by 0.16% from 2024 to 2025, a 0.2% decrease from the previous year and the same percentage the agency proposed in January.

3. The agency projected that its Medicare Advantage risk score trend of 3.86%, the average increase in adjustment payments year over year, will offset risk model revisions that will lead to a 2.45% decline in revenue and a projected decline in star rating bonuses.

4. CMS is projected to pay between $500 billion and $600 billion in MA payments to private health plans in 2025.

5. “These policies will put even more pressure on the benefits and premiums of 33 million Medicare Advantage beneficiaries who will be renewing their coverage this fall,” AHIP President Mike Tuffin said in an April 1 news release. “It is important to note that the Medicare Advantage and Part D programs are already undergoing a number of significant regulatory and legislative changes. Moreover, the cost of caring for Medicare Advantage beneficiaries is steadily rising.”

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-MetrixPaul Summers, Nevada Heart & Vascular

Advertisement

Next Up in Legal + Compensation

Advertisement

Comments are closed.